Bharat Book Bureau Provides the Trending Industry Research Report on“Radiopharmaceuticals in Nuclear Medicine Market - Global Outlook and Forecast 2022-2028”under Life Sciences Market Research Report. The report offers a collection of superior Market research, Market analysis, competitive intelligence and Market reports.

Executive Summary

This report contains market size and forecasts of Radiopharmaceuticals in Nuclear Medicine in global, including the following market information:


Global Radiopharmaceuticals in Nuclear Medicine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Radiopharmaceuticals in Nuclear Medicine Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Radiopharmaceuticals in Nuclear Medicine companies in 2021 (%)
The global Radiopharmaceuticals in Nuclear Medicine market was valued at 4943.7 million in 2021 and is projected to reach US$ 6857.2 million by 2028, at a CAGR of 4.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Diagnostic Radiopharmaceuticals Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Radiopharmaceuticals in Nuclear Medicine include Bracco Imaging S.P.A., Cambridge Isotope Laboratories, Inc., Cardinal Health, Inc., Covidien, Plc, Eczacibasi-Monrol, Fujifilm Holdings Corporation, GE Healthcare (Subsidiary Of General Electric Company), IBA Group and Isotec, Inc. (Sigma-Aldrich), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Radiopharmaceuticals in Nuclear Medicine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:
Global Radiopharmaceuticals in Nuclear Medicine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Radiopharmaceuticals in Nuclear Medicine Market Segment Percentages, by Type, 2021 (%)
Diagnostic Radiopharmaceuticals
Therapy Radiopharmaceuticals
Enriched Stable Isotopes
Global Radiopharmaceuticals in Nuclear Medicine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Radiopharmaceuticals in Nuclear Medicine Market Segment Percentages, by Application, 2021 (%)
Diagnostic Application
Therapeutic Application
Research
Pharmaceutical
Other
Global Radiopharmaceuticals in Nuclear Medicine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Radiopharmaceuticals in Nuclear Medicine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Radiopharmaceuticals in Nuclear Medicine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Radiopharmaceuticals in Nuclear Medicine revenues share in global market, 2021 (%)
Key companies Radiopharmaceuticals in Nuclear Medicine sales in global market, 2017-2022 (Estimated), (K MT)
Key companies Radiopharmaceuticals in Nuclear Medicine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bracco Imaging S.P.A.
Cambridge Isotope Laboratories, Inc.
Cardinal Health, Inc.
Covidien, Plc
Eczacibasi-Monrol
Fujifilm Holdings Corporation
GE Healthcare (Subsidiary Of General Electric Company)
IBA Group
Isotec, Inc. (Sigma-Aldrich)
Lantheus Medical Imaging, Inc.
Nordion, Inc.
Ntp Radioisotopes (Pty), Ltd.
Siemens Healthcare (Subsidiary Of Siemens AG)
Taiyo Nippon Sanso Corporation
Urenco Limited
Rotem Industries, Ltd., Inc.
Australian Nuclear Association And Technology Organization (ANSTO)
Board of Radiation And Isotope Technology (BRIT)
Institute of Atomic Energy Polatom Radioisotope Centre
Institute of Isotopes Co., Ltd.
Institute Of Radioelement (IRE)

Browse our full report with Table of Content : https://www.bharatbook.com/report/1330291/radiopharmaceuticals-in-nuclear-medicine-market-global-outlook-and-forecast

About Bharat Book Bureau:
Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 15,00,000 reports and insights that includes latest Industry Study, Industry Trends & Analysis, Forecasts Customized Intelligence, Newsletters and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ subsectors.

Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email: [email protected]
Website: www.bharatbook.com